|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Garrido-Castro AC, Lin NU and Polyak K:
Insights into molecular classifications of triple-negative breast
cancer: Improving patient selection for treatment. Cancer Discov.
9:176–198. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li Y, Zhang H, Merkher Y, Chen L, Liu N,
Leonov S and Chen Y: Recent advances in therapeutic strategies for
triple-negative breast cancer. J Hematol Oncol.
15(121)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Maroni P: Leptin, Adiponectin, and Sam68
in bone metastasis from breast cancer. Int J Mol Sci.
21(1051)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gu L, Wang CD, Cao C, Cai LR, Li DH and
Zheng YZ: Association of serum leptin with breast cancer: A
meta-analysis. Medicine (Baltimore). 98(e14094)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Niu J, Jiang L, Guo W, Shao L, Liu Y and
Wang L: The association between leptin level and breast cancer: A
meta-analysis. PLoS One. 8(e67349)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pan H, Deng LL, Cui JQ, Shi L, Yang YC,
Luo JH, Qin D and Wang L: Association between serum leptin levels
and breast cancer risk: An updated systematic review and
meta-analysis. Medicine (Baltimore). 97(e11345)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Miyoshi Y, Funahashi T, Tanaka S, Taguchi
T, Tamaki Y, Shimomura I and Noguchi S: High expression of leptin
receptor mRNA in breast cancer tissue predicts poor prognosis for
patients with high, but not low, serum leptin levels. Int J Cancer.
118:1414–1419. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang WJ, Lai HY, Zhang F, Shen WJ, Chu PY,
Liang HY, Liu YB and Wang JM: MCL1 participates in leptin-promoted
mitochondrial fusion and contributes to drug resistance in
gallbladder cancer. JCI Insight. 6(e135438)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen X, Zha X, Chen W, Zhu T, Qiu J, Røe
OD, Li J, Wang Z and Yin Y: Leptin attenuates the anti-estrogen
effect of tamoxifen in breast cancer. Biomed Pharmacother.
67:22–30. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ma L, Fan Z, Du G and Wang H:
Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in
pancreatic ductal adenocarcinoma. Biochem Biophys Res Commun.
509:845–853. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li K, Wei L, Huang Y, Wu Y, Su M, Pang X,
Wang N, Ji F, Zhong C and Chen T: Leptin promotes breast cancer
cell migration and invasion via IL-18 expression and secretion. Int
J Oncol. 48:2479–2487. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ojalvo LS, King W, Cox D and Pollard JW:
High-density gene expression analysis of tumor-associated
macrophages from mouse mammary tumors. Am J Pathol. 174:1048–1064.
2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nadella V, Garg M, Kapoor S, Barwal TS,
Jain A and Prakash H: Emerging neo adjuvants for harnessing
therapeutic potential of M1 tumor associated macrophages (TAM)
against solid tumors: Enusage of plasticity. Ann Transl Med.
8(1029)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li C, Xu X, Wei S, Jiang P, Xue L, Wang J
and Senior Correspondence: Tumor-associated macrophages: Potential
therapeutic strategies and future prospects in cancer. J Immunother
Cancer. 9(e001341)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cao H, Huang Y, Wang L, Wang H, Pang X, Li
K, Dang W, Tang H, Wei L, Su M, et al: Leptin promotes migration
and invasion of breast cancer cells by stimulating IL-8 production
in M2 macrophages. Oncotarget. 7:65441–65453. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fousek K, Horn LA and Palena C:
Interleukin-8: A chemokine at the intersection of cancer
plasticity, angiogenesis, and immune suppression. Pharmacol Ther.
219(107692)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cao W, Chen HD, Yu YW, Li N and Chen WQ:
Changing profiles of cancer burden worldwide and in China: A
secondary analysis of the global cancer statistics 2020. Chin Med J
(Engl). 134:783–791. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Seferbekova Z, Lomakin A, Yates LR and
Gerstung M: Spatial biology of cancer evolution. Nat Rev Genet.
24:295–313. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bejarano L, Jordāo MJC and Joyce JA:
Therapeutic targeting of the tumor microenvironment. Cancer Discov.
11:933–959. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Smrekar K, Belyakov A and Jin K: Crosstalk
between triple negative breast cancer and microenvironment.
Oncotarget. 14:284–293. 2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Singh A, Mayengbam SS, Yaduvanshi H, Wani
MR and Bhat MK: Obesity programs macrophages to support cancer
progression. Cancer Res. 82:4303–4312. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Habanjar O, Bingula R, Decombat C,
Diab-Assaf M, Caldefie-Chezet F and Delort L: Crosstalk of
inflammatory cytokines within the breast tumor microenvironment.
Int J Mol Sci. 24(4002)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Saxena NK, Vertino PM, Anania FA and
Sharma D: Leptin-induced growth stimulation of breast cancer cells
involves recruitment of histone acetyltransferases and mediator
complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem.
282:13316–13325. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yuan HJ, Sun KW and Yu K: Leptin promotes
the proliferation and migration of human breast cancer through the
extracellular-signal regulated kinase pathway. Mol Med Rep.
9:350–354. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang L, Tang C, Cao H, Li K, Pang X, Zhong
L, Dang W, Tang H, Huang Y, Wei L, et al: Activation of IL-8 via
PI3K/Akt-dependent pathway is involved in leptin-mediated
epithelial-mesenchymal transition in human breast cancer cells.
Cancer Biol Ther. 16:1220–1230. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Grossmann ME, Ray A, Nkhata KJ, Malakhov
DA, Rogozina OP, Dogan S and Cleary MP: Obesity and breast cancer:
Status of leptin and adiponectin in pathological processes. Cancer
Metastasis Rev. 29:641–653. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Orecchioni S, Reggiani F, Talarico G and
Bertolini F: Mechanisms of obesity in the development of breast
cancer. Discov Med. 20:121–128. 2015.PubMed/NCBI
|
|
30
|
Riolfi M, Ferla R, Del Valle L,
Piña-Oviedo S, Scolaro L, Micciolo R, Guidi M, Terrasi M, Cetto GL
and Surmacz E: Leptin and its receptor are overexpressed in brain
tumors and correlate with the degree of malignancy. Brain Pathol.
20:481–489. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gonzalez-Perez RR, Lanier V and Newman G:
Leptin's pro-angiogenic signature in breast cancer. Cancers
(Basel). 5:1140–1162. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Andò S and Catalano S: The multifactorial
role of leptin in driving the breast cancer microenvironment. Nat
Rev Endocrinol. 8:263–275. 2011.PubMed/NCBI View Article : Google Scholar
|
